Menu

SpecialtyChemicalsIndia

Urban Company IPO 2025: Subscription Buzz and Profit Milestone

Investor Frenzy: Chemkart, Smarten IPOs 5x Oversubscribed!

Investor Frenzy: Chemkart, Smarten IPOs 5x Oversubscribed!

High demand in the SME sector drives the Chemkart and Smarten Power IPOs, with allotments anticipated by July 10 and listings scheduled for July 14.

Summary:
The initial public offerings (IPOs) of Chemkart India and Smarten Power Systems have seen robust investor participation, each getting subscribed over five times their offer size. Allotment for both issues will be finalised by July 10, with shares set to debut on the BSE SME and NSE Emerge platforms on July 14.

IPO Boom in SME Space: Chemkart India and Smarten Power Systems Shine
The small and medium enterprise (SME) IPO space in India continues to witness strong traction as two recent public issues—Chemkart India and Smarten Power Systems—have both recorded over 5x subscription, signalling elevated investor enthusiasm for promising growth stories in niche sectors.
The subscription window for both IPOs closed recently, and investors are now eagerly awaiting the allotment status, which will be finalised by July 10, 2025. Chemkart India Ltd’s shares are set to be listed on the BSE SME platform, while Smarten Power Systems Ltd will make its debut on the NSE Emerge platform on July 14, 2025.

Chemkart India IPO: Interest Generated by Speciality Chemicals and API Focus
Company Overview:
Chemkart India is a rapidly growing chemical distribution company catering to the Active Pharmaceutical Ingredients (API) and speciality chemicals segment. With a wide customer base and strong supplier partnerships, the company provides critical raw materials for industries ranging from pharmaceuticals to agrochemicals and paints.
IPO Details:
Issue Size: ₹27.04 crore
Price Band: ₹99–₹105 per share
Lot Size: 1,200 shares
Use of Proceeds: Working capital requirements, general corporate purposes, and expansion of warehousing infrastructure.
Investor Response:
The Chemkart IPO was subscribed more than 5.3 times, driven largely by retail investors and HNIs, who accounted for the lion’s share of the bids. The company’s scalable business model, strong financials, and projected revenue growth made it attractive for investors betting on India’s booming chemical and pharmaceutical sectors.

Smarten Power Systems IPO: Riding the Clean Energy Wave
Company Overview:
Smarten Power Systems is a manufacturer of renewable energy products such as solar inverters, batteries, and power backup solutions. The company has witnessed rapid growth amid rising demand for energy-efficient and eco-friendly power solutions, particularly in rural and semi-urban India.
IPO Details:
Issue Size: ₹38.5 crore
Price Band: ₹96–₹102 per share
Lot Size: 1,200 shares
Use of Proceeds: Capital expenditure, R&D, marketing initiatives, and working capital.
Investor Response:
Smarten Power’s IPO was subscribed over 5.7 times, with significant traction from institutional investors betting on the green energy transition. The company’s strong product portfolio, growing distribution network, and alignment with government solar initiatives contributed to the robust response.

What Happens Next: Allotment & Listing Timeline
For both Chemkart and Smarten Power IPOs, the share allotment status is scheduled to be finalised by July 10, 2025. Refunds for shares that were not allotted will be processed by July 11, and the credit for allotted shares in the demat account is anticipated by July 13.
Listing Date for Both IPOs: July 14, 2025
Chemkart India: To be listed on BSE SME
Smarten Power Systems: To be listed on NSE Emerge
Investors should verify the allotment status on the official registrar websites or stock exchange portals.

Market Outlook: Why SME IPOs Are Gaining Traction
The SME IPO sector in India has experienced a revival in investor interest over the last two years. This is fueled by:
Improved financial disclosure norms
High-growth potential of niche companies
Reduced entry barriers for retail investors
Attractive valuations compared to mainboard IPOs
Chemkart and Smarten Power’s oversubscription reaffirms the sentiment that quality SMEs with solid fundamentals and strong growth narratives are capable of delivering multibagger returns post-listing.

Analyst Take:
Market analysts are optimistic about the listing performance of both companies. Given the high demand and investor interest, a robust opening is expected.
“Both companies operate in sectors aligned with structural growth trends—pharma for Chemkart and clean energy for Smarten Power. Post-listing performance will depend on their earnings trajectory and execution capabilities,” said Radhika Seth, a senior equity strategist at an investment firm.

Risks to Watch:
While investor interest is high, experts caution that SME stocks are generally less liquid and more volatile than mainboard stocks. Hence, long-term fundamentals and governance should remain the key drivers of investment decisions.

Conclusion:
The enthusiastic response to Chemkart India and Smarten Power Systems’ IPOs marks yet another successful chapter in India’s growing SME capital market story. With strong fundamentals, favourable sector outlooks, and investor optimism, these companies are poised to attract attention post-listing. However, investors should temper short-term listing expectations with long-term business performance and scalability.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Rupee Plummets Amid FII Outflows, Trade Concerns

Safex Chemicals Plans ₹450 Cr IPO to Strengthen Financial Health and Growth

Safex Chemicals Plans ₹450 Cr IPO to Strengthen Financial Health and Growth

Safex Chemicals Plans ₹450 Cr IPO to Strengthen Financial Health and Growth

Agrochemical specialist Safex Chemicals prepares for ₹450 crore public issue to strengthen balance sheet, reduce borrowings, and support business expansion.

Safex Chemicals Eyes Capital Markets with ₹450 Crore IPO Plan

Safex Chemicals, a producer in the specialty chemicals space, is preparing to roll out its maiden public share sale, aiming to generate approximately ₹450 crore in capital. The company has formally submitted its Draft Red Herring Prospectus (DRHP) to the Securities and Exchange Board of India (SEBI), signaling its intention to go public in the near term.

The IPO consists of a fresh issue of shares worth ₹450 crore alongside an Offer for Sale (OFS) of up to 3,57,34,818 equity shares, allowing existing shareholders to partially offload their holdings. A reserved portion of the offering has also been allocated for eligible employees, ensuring broader participation within the organization.

Offer Structure and Allotment Criteria

The public issue will follow a book-building process, a common approach in IPOs where demand determines the final price. According to the DRHP, the distribution of the offer will follow these norms:

• A maximum of half the offering is earmarked for allocation to qualified institutional investors (QIBs).
• At least 15% will go to non-institutional investors (NIIs)
• At least 35% of the total issue is designated for individual retail participants.

This allocation ensures that a healthy balance of institutional, high-net-worth, and retail investors can take part in the offering, promoting market diversity and liquidity.

Utilization of IPO Proceeds

Safex Chemicals plans to utilize the capital raised from the fresh issue primarily for debt reduction and operational needs. Below is a detailed division of the primary fund utilization segments:

• ₹255.59 crore is earmarked for repayment or prepayment of outstanding borrowings
• An amount of ₹110 crore is planned to be directed toward clearing outstanding borrowings incurred by its subsidiary, Shogun Organics.
• The remaining funds will go toward general corporate expenses, providing financial flexibility for future strategic initiatives

This reallocation of capital is expected to improve the company’s debt-to-equity ratio and free up internal resources for core business growth.

Company Background: Legacy in Agrochemical Innovation

Established in 1991, Safex Chemicals has grown into a well-recognized player within India’s agrochemical and specialty chemicals landscape. The company focuses on delivering solutions in three major verticals:

• Branded formulations
• Specialty chemical products
• Contract development and manufacturing (CDMO)

Its diverse offerings are tailored to the needs of Indian farmers and international agrochemical firms. Safex has steadily built its reputation for delivering innovative and effective chemical solutions that support modern agriculture and crop protection.

Financial Performance: Revenue Growth Amid Bottom-Line Pressure

Despite experiencing net losses in recent years, Safex Chemicals has recorded robust revenue growth, highlighting the strength of its operational model. A quick overview of the company’s latest financial metrics is outlined below:

Revenue Growth (Consolidated):
• FY23: ₹1,161.02 crore
• FY24: ₹1,404.59 crore
• FY25: ₹1,584.78 crore

Net Profit/Loss (Consolidated):
• FY23: ₹(1.02) crore
• FY24: ₹(22.79) crore
• FY25: ₹(14.29) crore

EBITDA and Margins:
• FY23: ₹149.06 crore (EBITDA margin: 12.84%)
• FY24: ₹118.65 crore (EBITDA margin: 8.45%)
• FY25: ₹233.03 crore (EBITDA margin: 14.70%)

These figures suggest that although profitability has faced headwinds, particularly in FY24, the company has rebounded significantly in FY25 in terms of operational efficiency, as reflected by the improved EBITDA margin.

Growth Strategy and Market Outlook

Safex Chemicals’ IPO move comes at a time when India’s agrochemical and specialty chemical industries are poised for long-term expansion, driven by increasing agricultural needs, global export demand, and regulatory tailwinds for domestic manufacturing.

The company’s decision to clear a substantial portion of its debt signals a strategic shift toward financial consolidation and operational scalability. Additionally, Safex’s involvement in contract development and manufacturing (CDMO) opens avenues for B2B partnerships with global players, potentially enhancing revenue diversity and margin resilience.

With IPO proceeds providing a stronger financial foundation, Safex is expected to channel investments into R&D, production enhancements, and market outreach—further solidifying its competitive edge.

Final Thoughts

Safex Chemicals’ planned ₹450 crore IPO marks a pivotal step in its journey from a long-standing private enterprise to a publicly listed player in India’s high-potential chemical industry. The funds raised will primarily help reduce debt burdens and support operational scaling, especially for its subsidiary Shogun Organics.

Despite recent net losses, the company’s revenue momentum and rebound in EBITDA margins demonstrate underlying business strength and operational resilience. With a 30+ year legacy in agrochemical solutions and a growing role in global supply chains, Safex Chemicals is positioning itself for the next phase of growth with greater agility, transparency, and investor participation.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Adani Enterprises to Roll Out ₹1,000 Crore NCD Issue with Up to 9.30% Returns